Retraction
Reducing the stigma of long acting injectable antipsychotics – current concepts and future developments
Paper Information
Record ID:
29139
Author(s):
Journal:
Publication Date:
January 27, 2019
Retraction Date:
May 31, 2021
(4.5 years years ago)
Subjects:
Institutions:
- Pharmacy Department Denmark Hill, Maudsley Hospital, London, UK
- King's College London Institute of Pharmaceutical Science , London , UK
- Department of Health Sciences , Lulea University of Technology , Lulea , Sweden
- Department of Clinical Sciences, Division of Psychiatry, Sunderby Research Unit, Umeå University, Umeå, Sweden
Countries:
Article Type:
Publisher:
Taylor and Francis
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reason:
Nature of Retraction:
Retraction
Retraction Notice:
10.1080/08039488.2021.1931745Citations (23)
23
Total Citations14
Post-Retraction(60.9%)
9
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
6
Within 1 year
5
After 2+ years
1484
Days since retraction (latest)
Long-term outcomes of Aripiprazole long-acting injectable: a 10-year mirror image study of patient acceptability and treatment effectiveness
Joshua Barnett, Sofia Pappa
Schizophrenia
Open Access
Published: Jun 2025
1484 days after retraction
The Advances in Antipsychotics-Induced Dyskinesia Rodent Models: Benefits of Antioxidant Supplementation
Uros Velickovic, Dragica Selaković, Nemanja Jovičić et al. (9 authors)
Biomedicines
Open Access
Published: Feb 2025
1359 days after retraction
Schizophrenia and Heart Health: Are Antipsychotics a Friend or Foe?
Minodora Andor, Liana Dehelean, Diana-Aurora Arnăutu et al. (8 authors)
Journal of Personalized Medicine
Open Access
Published: Jul 2024
1 citation
1 citation
1157 days after retraction
Antipsychotic Drugs
Sarang Naresh Kshirsagar, Tapas Kumar Sahoo
Unknown Journal
Published: Jan 2024
945 days after retraction
Comparative Safety of Long-Acting Injectable Antipsychotics: A Systematic Review and Network Meta-Analysis
Erasmo Saucedo Uribe, Samuel Enrique Olivares Mundo, Raúl Ricardo Medrano-Garza et al. (11 authors)
Psychiatry Investigation
Open Access
Published: Dec 2023
1 citation
1 citation
932 days after retraction
Long-acting antipsychotics in the treatment of schizophrenia: opportunities and challenges
Peter Haddad, Christoph U. Correll
Expert Opinion on Pharmacotherapy
Published: Mar 2023
21 citations
21 citations
642 days after retraction
Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine
Gabriel G. Edwards, Ayako Miyashita-Ochoa, Enrico G. Castillo et al. (14 authors)
AIDS and Behavior
Open Access
Published: Sep 2022
13 citations
13 citations
462 days after retraction
Attitudes and perceptions about the use of long-acting injectable antipsychotics among behavioral health practitioners
Shaina Schwartz, Christina Carilli, Taimur Mian et al. (5 authors)
Mental Health Clinician
Open Access
Published: Aug 2022
10 citations
10 citations
427 days after retraction
Switch from Olanzapine Long-Acting Injectable to its Oral Equivalent during COVID-19 Pandemic: a Real World Observational Study
Ana-Aliana Miron, Andreea Teodorescu, Petru Ifteni et al. (6 authors)
Psychiatric Quarterly
Open Access
Published: Mar 2022
9 citations
9 citations
275 days after retraction
Development and Evaluation of a Web-Based Educational Toolkit on the Knowledge, Attitudes, and Practices of Psychiatric Prescribers Regarding Long-Acting Injectable Antipsychotics
Lisa M. Lewis, Jill Rodgers
Journal of the American Psychiatric Nurses Association
Published: Feb 2022
1 citation
1 citation
262 days after retraction
Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries
Giovanni Ostuzzi, Chiara Gastaldon, Davide Papola et al. (4 authors)
Epidemiology and Psychiatric Sciences
Open Access
Published: Jan 2022
7 citations
7 citations
215 days after retraction
Rating Opportunity for Long-Acting Injectable Antipsychotic Initiation Index (ROLIN)
Petru Ifteni, Paula-Simina Petric, Andreea Teodorescu
Frontiers in Psychiatry
Open Access
Published: Dec 2021
4 citations
4 citations
190 days after retraction
Attitudes and Willingness to Accept Long-Acting Injections for Patients With Schizophrenia in Beijing: A Cross-Sectional Investigation Based on Samples From the Communities
Junli Zhu, Yun Chen, Wei Lu et al. (8 authors)
Frontiers in Public Health
Open Access
Published: Nov 2021
11 citations
11 citations
178 days after retraction
Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
John M. Kane, Joseph P. McEvoy, Christoph U. Correll et al. (4 authors)
CNS Drugs
Open Access
Published: Oct 2021
53 citations
53 citations
133 days after retraction
Schizophrenia Long-Acting Injectable Antipsychotic Initiation Index: A Clinician Rated Instrument for Improving Treatment in Schizophrenia
Petru Ifteni, Andreea Teodorescu
Research Square (Research Square)
Open Access
Published: Apr 2021
39 days before retraction
Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study
Federico Bertolini, Giovanni Ostuzzi, Michela Pievani et al. (18 authors)
CNS Drugs
Open Access
Published: Mar 2021
20 citations
20 citations
63 days before retraction
Treatment strategies in management of schizophrenia patients with persistent symptoms in daily practice: a retrospective study
Ahmet Kokurcan, Seher Olga Güriz, Hasan Karadağ et al. (5 authors)
International Journal of Psychiatry in Clinical Practice
Published: Feb 2021
7 citations
7 citations
112 days before retraction
Antipsychotic use among persons with schizophrenia in Sweden and Finland, trends and differences
Heidi Taipale, Arto Puranen, Ellenor Mittendorfer‐Rutz et al. (7 authors)
Nordic Journal of Psychiatry
Open Access
Published: Dec 2020
21 citations
21 citations
165 days before retraction
Leucopenia during paliperidone treatment in a patient with schizoaffective disorder – a case study
Bertrand Janota, Paulina Michalska, Anna Szymanik-Kostrzewska et al. (4 authors)
Psychiatria i Psychologia Kliniczna
Open Access
Published: Nov 2020
182 days before retraction
Ingestible Sensors and Medication Adherence: Focus on Use in Serious Mental Illness
Azita Alipour, Stephen Gabrielson, Puja Patel
Pharmacy
Open Access
Published: Jun 2020
36 citations
36 citations
349 days before retraction
Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challenge
Petru Ifteni, Lorena Dima, Andreea Teodorescu
Schizophrenia Research
Open Access
Published: Apr 2020
37 citations
37 citations
399 days before retraction
Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study
Corrado Barbui, Federico Bertolini, Francesco Bartoli et al. (15 authors)
Therapeutic Advances in Psychopharmacology
Open Access
Published: Jan 2020
20 citations
20 citations
516 days before retraction
The Gut Microbiome and Treatment-Resistance in Schizophrenia
Mary V. Seeman
Psychiatric Quarterly
Published: Nov 2019
11 citations
11 citations
550 days before retraction
Quick Stats
Total Citations:
23
Years Since Retraction:
4.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025